Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-.
Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as ATPases. They exist as complexes with modification methylases of similar specificity listed under EC 2.1.1.72 or EC 2.1.1.73. The systems recognize specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.5.
Enzyme systems containing three different subunits and requiring ATP, S-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent ATPases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognize specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.3.
Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4.

Identification of RNase T as a high-copy suppressor of the UV sensitivity associated with single-strand DNA exonuclease deficiency in Escherichia coli. (1/2430)

There are three known single-strand DNA-specific exonucleases in Escherichia coli: RecJ, exonuclease I (ExoI), and exonuclease VII (ExoVII). E. coli that are deficient in all three exonucleases are abnormally sensitive to UV irradiation, most likely because of their inability to repair lesions that block replication. We have performed an iterative screen to uncover genes capable of ameliorating the UV repair defect of xonA (ExoI-) xseA (ExoVII-) recJ triple mutants. In this screen, exonuclease-deficient cells were transformed with a high-copy E. coli genomic library and then irradiated; plasmids harvested from surviving cells were used to seed subsequent rounds of transformation and selection. After several rounds of selection, multiple plasmids containing the rnt gene, which encodes RNase T, were found. An rnt plasmid increased the UV resistance of a xonA xseA recJ mutant and uvrA and uvrC mutants; however, it did not alter the survival of xseA recJ or recA mutants. RNase T also has amino acid sequence similarity to other 3' DNA exonucleases, including ExoI. These results suggest that RNase T may possess a 3' DNase activity capable of substituting for ExoI in the recombinational repair of UV-induced lesions.  (+info)

Chromatin structure: a property of the higher structures of chromatin and in the time course of its formation during chromatin replication. (2/2430)

The action of a number of enzymes and metals on one nuclear preparation were interpreted in terms of the existence of a fragile but highly DNAase-I resistant feature of chromatin superstructure. The generation of this DNAase-I resistance feature of chromatin was then followed during normal DNA synthesis in the regenerating rat liver by following the disappearance of a transitory DNAase-I susceptible state. This transitory, DNAase-I susceptible state appears to be extremely similar to the post-synthetic, DNAase-I susceptible state that has been described in He La32.  (+info)

A unique DNase activity shares the active site with ATPase activity of the RecA/Rad51 homologue (Pk-REC) from a hyperthermophilic archaeon. (3/2430)

A RecA/Rad51 homologue from Pyrococcus kodakaraensis KOD1 (Pk-REC) is the smallest protein among various RecA/Rad51 homologues. Nevertheless, Pk-Rec is a super multifunctional protein and shows a deoxyribonuclease activity. This deoxyribonuclease activity was inhibited by 3 mM or more ATP, suggesting that the catalytic centers of the ATPase and deoxyribonuclease activities are overlapped. To examine whether these two enzymatic activities share the same active site, a number of site-directed mutations were introduced into Pk-REC and the ATPase and deoxyribonuclease activities of the mutant proteins were determined. The mutant enzyme in which double mutations Lys-33 to Ala and Thr-34 to Ala were introduced, fully lost both of these activities, indicating that Lys-33 and/or Thr-34 are important for both ATPase and deoxyribonuclease activities. The mutation of Asp-112 to Ala slightly and almost equally reduced both ATPase and deoxyribonuclease activities. In addition, the mutation of Glu-54 to Gln did not seriously affect the ATPase, deoxyribonuclease, and UV tolerant activities. These results strongly suggest that the active sites of the ATPase and deoxyribonuclease activities of Pk-REC are common. It is noted that unlike Glu-96 in Escherichia coli RecA, which has been proposed to be a catalytic residue for the ATPase activity, the corresponding residual Glu-54 in Pk-REC is not involved in the catalytic function of the protein.  (+info)

Hepatocyte nuclear factor-4 regulates intestinal expression of the guanylin/heat-stable toxin receptor. (4/2430)

We have investigated the regulation of gene transcription in the intestine using the guanylyl cyclase C (GCC) gene as a model. GCC is expressed in crypts and villi in the small intestine and in crypts and surface epithelium of the colon. DNase I footprint, electrophoretic mobility shift assay (EMSA), transient transfection assays, and mutagenesis experiments demonstrated that GCC transcription is regulated by a critical hepatocyte nuclear factor-4 (HNF-4) binding site between bp -46 and -29 and that bp -38 to -36 were essential for binding. Binding of HNF-4 to the GCC promoter was confirmed by competition EMSA and by supershift EMSA. In Caco-2 and T84 cells, which express both GCC and HNF-4, the activity of GCC promoter and/or luciferase reporter plasmids containing 128 or 1973 bp of 5'-flanking sequence was dependent on the HNF-4 binding site in the proximal promoter. In COLO-DM cells, which express neither GCC nor HNF-4, cotransfection of GCC promoter/luciferase reporter plasmids with an HNF-4 expression vector resulted in 23-fold stimulation of the GCC promoter. Mutation of the HNF-4 binding site abolished this transactivation. Transfection of COLO-DM cells with the HNF-4 expression vector stimulated transcription of the endogenous GCC gene as well. These results indicate that HNF-4 is a key regulator of GCC expression in the intestine.  (+info)

In vivo nuclease hypersensitivity studies reveal multiple sites of parental origin-dependent differential chromatin conformation in the 150 kb SNRPN transcription unit. (5/2430)

Human chromosome region 15q11-q13 contains a cluster of oppositely imprinted genes. Loss of the paternal or the maternal alleles by deletion of the region or by uniparental disomy 15 results in Prader-Willi syndrome (PWS) or Angelman syndrome (AS), respectively. Hence, the two phenotypically distinct neurodevelopmental disorders are caused by the lack of products of imprinted genes. Subsets of PWS and AS patients exhibit 'imprinting mutations', such as small microdeletions within the 5' region of the small nuclear ribonucleoprotein polypeptide N ( SNRPN ) transcription unit which affect the transcriptional activity and methylation status of distant imprinted genes throughout 15q11-q13 in cis. To elucidate the mechanism of these long-range effects, we have analyzed the chromatin structure of the 150 kb SNRPN transcription unit for DNase I- and Msp I-hypersensitive sites. By using an in vivo approach on lymphoblastoid cell lines from PWS and AS individuals, we discovered that the SNRPN exon 1 is flanked by prominent hypersensitive sites on the paternal allele, but is completely inaccessible to nucleases on the maternal allele. In contrast, we identified several regions of increased nuclease hypersensitivity on the maternal allele, one of which coincides with the AS minimal microdeletion region and another lies in intron 1 immediately downstream of the paternal-specific hypersensitive sites. At several sites, parental origin-specific nuclease hypersensitivity was found to be correlated with hypermethylation on the allele contributed by the other parent. The differential parental origin-dependent chromatin conformations might govern access of regulatory protein complexes and/or RNAs which could mediate interaction of the region with other genes.  (+info)

Cloning of mnuA, a membrane nuclease gene of Mycoplasma pulmonis, and analysis of its expression in Escherichia coli. (6/2430)

Membrane nucleases of mycoplasmas are believed to play important roles in growth and pathogenesis, although no clear evidence for their importance has yet been obtained. As a first step in defining the function of this unusual membrane activity, studies were undertaken to clone and analyze one of the membrane nuclease genes from Mycoplasma pulmonis. A novel screening strategy was used to identify a recombinant lambda phage expressing nuclease activity, and its cloned fragment was analyzed. Transposon mutagenesis was used to identify an open reading frame of 1,410 bp, which coded for nuclease activity in Escherichia coli. This gene coded for a 470-amino-acid polypeptide of 53,739 Da and was designated mnuA (for "membrane nuclease"). The MnuA protein contained a prolipoprotein signal peptidase II recognition sequence along with an extensive hydrophobic region near the amino terminus, suggesting that the protein may be lipid modified or that it is anchored in the membrane by this membrane-spanning region. Antisera raised against two MnuA peptide sequences identified an M. pulmonis membrane protein of approximately 42 kDa by immunoblotting, which corresponded to a trypsin-sensitive nucleolytic band of the same size. Maxicell experiments with E. coli confirmed that mnuA coded for a nuclease of unknown specificity. Hybridization studies showed that mnuA sequences are found in few Mycoplasma species, suggesting that mycoplasma membrane nucleases display significant sequence variation within the genus Mycoplasma.  (+info)

The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. (7/2430)

Streptococcus pyogenes produces several extracellular proteins, including streptococcal erythrogenic toxin B (SPE B), also known as streptococcal pyrogenic exotoxin B and streptococcal proteinase. Several reports suggest that SPE B contributes to the virulence associated with S. pyogenes; however, little is known about its regulation. Nucleotide sequence data revealed the presence, upstream of the speB gene, of a gene, designated rgg, that was predicted to encode a polypeptide similar to previously described positive regulatory factors. The putative Rgg polypeptide of S. pyogenes NZ131 consisted of 280 amino acids and had a predicted molecular weight of 33,246. To assess the potential role of Rgg in the production of SPE B, the rgg gene was insertionally inactivated in S. pyogenes NZ131, which resulted in markedly decreased SPE B production, as determined both by immunoblotting and caseinolytic activity on agar plates. However, the production of other extracellular products, including streptolysin O, streptokinase, and DNase, was not affected. Complementation of the rgg mutant with an intact rgg gene copy in S. pyogenes NZ131 could restore SPE B production and confirmed that the rgg gene product is involved in the production of SPE B.  (+info)

A novel endonuclease of human cells specific for single-stranded DNA. (8/2430)

We have fractionated from human aneuploid cell cultures three different enzyme fractions degrading single-stranded DNA. We have purified and characterized one of these DNases; this is an endonuclease working at alkaline pH (around 9.5) and requiring Mg2+ for its activity. The enzyme degrades denatured DNA over 100 times more efficiently than native DNA in optimal conditions. The termini produced by the enzyme have 5'P and 3'OH ends. The enzyme can attack, though at reduced rate, the supertwisted circular molecule of Simian virus 40 DNA, whereas it is inactive on the nicked circular molecule. The ultraviolet irradiation of DNA, whether native or denatured, does not affect its efficiency as substrate of the DNase. The properties of this endonuclease distinguish it from those of the other DNases described previously in mammalian cells; the denomination DNase VI is therefore proposed. Its properties are similar to those of DNases described in Ustilago maydis and Bacillus subtilis, for which an essential role in recombination seems likely.  (+info)

Deoxyribonucleases (DNases) are a group of enzymes that cleave, or cut, the phosphodiester bonds in the backbone of deoxyribonucleic acid (DNA) molecules. DNases are classified based on their mechanism of action into two main categories: double-stranded DNases and single-stranded DNases.

Double-stranded DNases cleave both strands of the DNA duplex, while single-stranded DNases cleave only one strand. These enzymes play important roles in various biological processes, such as DNA replication, repair, recombination, and degradation. They are also used in research and clinical settings for applications such as DNA fragmentation analysis, DNA sequencing, and treatment of cystic fibrosis.

It's worth noting that there are many different types of DNases with varying specificities and activities, and the medical definition may vary depending on the context.

Deoxyribonucleases, Type III Site-Specific are a type of enzyme that cleaves DNA at specific sequences. They are also known as restriction endonucleases and are found in bacteria, where they play a role in the defense against foreign DNA, such as that from viruses. These enzymes recognize and bind to specific sites on the DNA molecule, and then cut the phosphodiester bonds between the sugar and phosphate groups of the DNA backbone, resulting in double-stranded breaks at the recognition site. The ends of the cleaved DNA molecules are often "sticky" or complementary to each other, allowing for the joining of DNA fragments from different sources through a process called ligation.

Type III restriction enzymes are unique because they require two recognition sites in close proximity to each other on the same DNA molecule in order to cleave the DNA. They also have both endonuclease and methyltransferase activities, which allows them to modify their own recognition site to prevent self-destruction.

These enzymes are widely used in molecular biology research for various purposes such as cloning, genome editing, and DNA fingerprinting.

Deoxyribonucleases, Type I Site-Specific are a group of enzymes that cleave the phosphodiester bonds in the DNA backbone at specific recognition sites. They are also known as restriction endonucleases or restriction enzymes. These enzymes play a crucial role in the restriction modification system, which provides bacterial and archaeal cells with a defense mechanism against foreign DNA, such as that of bacteriophages (viruses that infect bacteria).

Type I site-specific deoxyribonucleases are complex multifunctional enzymes composed of several subunits. They have three main activities: sequence-specific double-stranded DNA cleavage, ATP-dependent DNA translocation, and methylation of recognition sites. These enzymes recognize specific palindromic sequences in the DNA (usually 4-8 base pairs long) and cleave the phosphodiester bond at a defined distance from the recognition site, often resulting in staggered cuts that leave overhanging single-stranded ends.

Type I restriction enzymes require magnesium ions as cofactors for their endonuclease activity and ATP for their translocase activity. They are generally less specific than other types of restriction enzymes (Types II and III) since they cleave DNA within a broader range around the recognition site, rather than at fixed positions.

The restriction-modification system consists of two components: a restriction endonuclease (such as Type I deoxyribonucleases) that cuts foreign DNA at specific sites and a methyltransferase that modifies the host's DNA by adding methyl groups to the same recognition sites, protecting it from cleavage. This system allows the cell to distinguish between its own DNA and foreign DNA, providing an effective defense mechanism against invading genetic elements.

In summary, Deoxyribonucleases, Type I Site-Specific are restriction endonucleases that recognize specific sequences in double-stranded DNA and cleave the phosphodiester bonds at defined distances from the recognition site. They play a critical role in the bacterial and archaeal defense system against foreign DNA by selectively degrading invading genetic elements while sparing the host's methylated DNA.

Deoxyribonucleases, Type II Site-Specific are a type of enzymes that cleave phosphodiester bonds in DNA molecules at specific recognition sites. They are called "site-specific" because they cut DNA at particular sequences, rather than at random or nonspecific locations. These enzymes belong to the class of endonucleases and play crucial roles in various biological processes such as DNA recombination, repair, and restriction.

Type II deoxyribonucleases are further classified into several subtypes based on their cofactor requirements, recognition site sequences, and cleavage patterns. The most well-known examples of Type II deoxyribonucleases are the restriction endonucleases, which recognize specific DNA motifs in double-stranded DNA and cleave them, generating sticky ends or blunt ends. These enzymes are widely used in molecular biology research for various applications such as genetic engineering, cloning, and genome analysis.

It is important to note that the term "Deoxyribonucleases, Type II Site-Specific" refers to a broad category of enzymes with similar properties and functions, rather than a specific enzyme or family of enzymes. Therefore, providing a concise medical definition for this term can be challenging, as it covers a wide range of enzymes with distinct characteristics and applications.

  • Deoxyribonuclease (DNase, for short) refers to a group of glycoprotein endonucleases which are enzymes that catalyze the hydrolytic cleavage of phosphodiester linkages in the DNA backbone, thus degrading DNA. (wikipedia.org)
  • A wide variety of deoxyribonucleases are known and fall into one of two families (DNase I or DNase II), which differ in their substrate specificities, chemical mechanisms, and biological functions. (wikipedia.org)
  • The two main types of DNase found in animals are known as deoxyribonuclease I (DNase I) and deoxyribonuclease II (DNase II). (wikipedia.org)
  • Deoxyribonuclease I (DNase I) is an endonuclease isolated from bovine pancreas that digests double and single stranded DNA into oligo and mononucleotides. (sigmaaldrich.com)
  • A deoxyribonuclease ( DNase , for short) is any enzyme that catalyzes the hydrolytic cleavage of phosphodiester linkages in the DNA backbone. (wikidoc.org)
  • It can block RNase and deoxyribonuclease (DNase) activity. (sigmaaldrich.com)
  • Deoxyribonuclease (DNase) I Solution (1 mg/mL) is useful to reduce or prevent the clumping of concentrated and/or cryopreserved cell suspensions following thawing. (stemcell.com)
  • LongLifeā„¢ DNase (Deoxyribonuclease) is a ready to use DNase I preparation provided with a co-factor bivalent metal ion. (gbiosciences.com)
  • I personally believe that the work helps to raise awareness for the potential use of deoxyribonuclease (DNase), an enzyme that acts to clear NETs by dissolving the DNA strands, in the acute treatment of STEMI. (the-hospitalist.org)
  • 0.001) and was apparent by 6 weeks, irrespective of concomitant recombinant human deoxyribonuclease (rhDNase) use. (nih.gov)
  • A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. (nih.gov)
  • Using a strategy previously tested in patients with CF, they treated a small group of patients with severe COVID-19 symptoms with enzyme recombinant human deoxyribonuclease I, or rhDNase, which degrades extracellular DNA in the sputum. (asbmb.org)
  • Part of this material was treated with pancreatic deoxyribonuclease. (duke.edu)
  • Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Deoxyribonuclease I (DNASE1) in serum, plasma, urine, saliva, seminal plasma and other biological fluids. (tissue-cell-culture.com)
  • Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Deoxyribonuclease I (DNASE1) in samples from Serum, plasma, urine, saliva, seminal plasma and other biological fluids with no significant corss-reactivity with analogues from other species. (tissue-cell-culture.com)
  • Description: A sandwich ELISA kit for detection of Deoxyribonuclease I from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. (tissue-cell-culture.com)
  • A wide variety of deoxyribonucleases are known, which differ in their substrate specificities, chemical mechanisms, and biological functions. (wikidoc.org)
  • Two deoxyribonuclease I gene polymorphisms and correlation between genotype and its activity in Japanese population. (cdc.gov)
  • Deoxyribonucleases are thus one type of nuclease . (wikidoc.org)
  • We report the case of a 77-year-old Caucasian man with severe dementia and behavioral disturbance secondary to Alzheimer's disease treated with memantine who began adjunct treatment with deoxyribonuclease I. Prior to initiation of deoxyribonuclease I treatment, our patient appeared to be in a stuporous state, with a Mini-Mental State Examination score of 3 and a Functional Assessment Staging Test score of 7. (medscape.com)
  • This graph shows the total number of publications written about "Deoxyribonuclease I" by people in this website by year, and whether "Deoxyribonuclease I" was a major or minor topic of these publications. (umassmed.edu)
  • After obtaining informed consent from family members, we started administration of 120 mg of deoxyribonuclease I per day (1500 KU/mg) for treatment of severe cognitive impairment. (medscape.com)
  • Our patient began to demonstrate rapid, considerable improvement in cognitive function 2 days following initiation of deoxyribonuclease I treatment. (medscape.com)
  • Deoxyribonuclease and competence factor activities of transformable and nontransformable group H streptococci. (cornell.edu)

No images available that match "deoxyribonucleases"